about
Separation of prescribing and dispensing in Malaysia: the history and challenges.Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT PathwayJerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancersGlobal Antimicrobial Stewardship: A Closer Look at the Formidable Implementation Challenges.Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers.Targeting legumain as a novel therapeutic strategy in cancers.Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.Mechanisms Underlying the Anti-Inflammatory Effects of Clinacanthus nutans Lindau Extracts: Inhibition of Cytokine Production and Toll-Like Receptor-4 Activation.Academic integrity of health care educators: requisite for nurturing professionalism.A Bis-benzopyrroloisoquinoline Alkaloid Incorporating a Cyclobutane Core and a Chlorophenanthroindolizidine Alkaloid with Cytotoxic Activity from Ficus fistulosa var. tengerensis.Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles.Additivity vs Synergism: Investigation of the Additive Interaction of Cinnamon Bark Oil and Meropenem in Combinatory Therapy.Lutein improves cell viability and reduces Alu RNA accumulation in hydrogen peroxide challenged retinal pigment epithelial cells.Drug-like dietary vanilloids induce anticancer activity through proliferation inhibition and regulation of bcl-related apoptotic proteins.Identification of inhibitors synergizing gemcitabine sensitivity in the squamous subtype of pancreatic ductal adenocarcinoma (PDAC).Epigenetics in Metastatic Breast Cancer: Its Regulation and Implications in Diagnosis, Prognosis and TherapeuticsChallenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer TherapyTocotrienols Modulate a Life or Death Decision in CancersTherapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironmentComparative efficacy of vanilloids in inhibiting toll-like receptor-4 (TLR-4)/myeloid differentiation factor (MD-2) homodimerisationAdvancing Pharmacy Service using Big Data - Are We Fully Utilising the Big Data's Potential Yet?The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinomaAcademic dishonesty among academics in Malaysia: a comparison between healthcare and non-healthcare academicsAlstoscholactine and Alstolaxepine, Monoterpenoid Indole Alkaloids with γ-Lactone-Bridged Cycloheptane and Oxepane Moieties from Alstonia scholarisZebularine and trichostatin A sensitized human breast adenocarcinoma cells towards tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosisHistone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneouslySphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1The synthesis of trifluoromethylated N-nitroaryl-2-amino-1,3-dichloropropane derivatives and their evaluation as potential anti-cancer agentsNovel 2-Benzoyl-6-(2,3-Dimethoxybenzylidene)-Cyclohexenol Confers Selectivity toward Human MLH1 Defective Cancer Cells through Synthetic LethalityGoniolanceolatins A-H, Cytotoxic Bis-styryllactones from Goniothalamus lanceolatus
P50
Q34509441-AEDA1130-3D1C-4906-985B-391BCA99AB44Q36255950-F9237054-E308-4FBD-8645-ADFABE61A2AFQ36280761-1BFEA573-6EE4-4CDD-821E-0C17E1E549EEQ37291780-A2E6C378-1273-4F85-A4B6-ED913791ABD2Q37416040-C97CA41E-4CB7-490C-9593-20A8787F91B2Q38632218-1B7DF4C1-355B-4C13-A28E-7E6ADB8426B0Q38780716-FC42CFF2-C7C4-43DB-82BB-2670B9BA1EC1Q39011086-B4D02D00-C72C-48A6-8136-497E81CD2CA7Q39176750-AF0D3135-DB96-49E1-BCDE-658355B4F28BQ47931866-4188DA75-8491-43DD-B052-329502395CE5Q47961889-E2E4784E-2F48-4C14-906D-95D8F71D999AQ48108671-34CA25AF-CC6A-46E0-BFB8-55BE180791DBQ48348378-3805A090-2A9E-47DD-8C4F-F609A13DD7B5Q48364825-A1571795-871F-4D73-A069-8DDBBC475E30Q49719674-A9E4C13B-27A7-4B9C-96EE-EBABA0200C16Q54979490-27922C49-DDC1-49BE-97CC-85E7C4C996D9Q57113389-263D3A30-2133-457B-9699-53839C7D8DFAQ59808744-77662F5F-2F36-4D58-B082-4C2F9FEB9AECQ61815073-C135741B-84B8-473A-B6CD-5487D2C96D2EQ64113812-7B680AF3-A7AD-423C-BA9D-CB3B52D50457Q88888650-C71A1AB4-88F3-43B6-BB54-DD878BF60F8AQ89212047-E2127F44-333A-4D6C-9C13-BC38078E606DQ90106978-C11F491F-FFD2-4C92-963B-64A64615EAC5Q90285364-2F84020C-C164-46B1-86AF-94AB1DAD34F4Q90447006-5AA80C2A-C419-4F5D-B8CF-AB7FDD0E332CQ91115752-989062C7-D880-4E4D-8FC4-5A33EF34AB94Q91561369-396D0CFE-315B-4E36-A17E-D3ADB55D6BB6Q91670120-829694E4-D0CA-4FDA-99B6-F08D21CDE217Q92285804-9EA6A0B2-12DA-43ED-997E-EE620BF5CE97Q92526018-564E0096-EAAD-43F8-BC95-63D3861B69A9Q92746083-B33435E7-6433-49E5-AF4F-1E126042E45E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chun W Mai
@nl
Chun W Mai
@sl
Chun W. Mai
@en
Chun W. Mai
@es
type
label
Chun W Mai
@nl
Chun W Mai
@sl
Chun W. Mai
@en
Chun W. Mai
@es
prefLabel
Chun W Mai
@nl
Chun W Mai
@sl
Chun W. Mai
@en
Chun W. Mai
@es
P1053
M-3972-2013
P106
P1153
55637946600
P2038
Chun_Wai_Mai
P2798
P31
P3829
P496
0000-0001-6532-184X
P569
2000-01-01T00:00:00Z